These concepts are illustrated here with the specific case of the human glucocorticoid receptor, a medically important multi-domain allosteric protein that contains Read More

GainTherapeutics
Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. Gain was originally established in 2017 with the support of its founders and institutional investors such as TiVenture, 3B Future Health Fund (previously known as Helsinn Investment Fund) and VitaTech.
If it is possible to unfold the inactive state, it can reduce binding incompetence arising from folding or conformational dynamics. Thus, the Read More
The allosteric effect is an important mechanism of regulation in the biological process that binds the ligand on one side of the Read More
Prion disease, which is also known as transmissible spongiform encephalopathies or TSEs are a rare group of neurodegenerative disorders affecting both mammals Read More